![Todd Simpson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Simpson
Directeur/Bestuurslid bij
XENCOR, INC.
Vermogen: 654 033 $ op 31-08-2026
Profiel
Momenteel is Todd E. Simpson voorzitter voor Neoleukin Therapeutics, Inc. en Chief Financial Officer voor Seagen Inc. De heer Simpson zit ook in de raad van bestuur van Cascadian Therapeutics, Inc. en de Washington Biotechnology & Biomedical Association. In zijn vorige loopbaan was hij CFO, VP-Finance & Administration bij Vericel Corp., Treasurer bij Integra LifeSciences Holdings Corp. en Chief Financial Officer & Vice President van Telios Pharmaceuticals, Inc. (een dochteronderneming van Integra LifeSciences Holdings Corp.), CFO & VP-Finance & Administration bij AmpliPhi Biosciences Corp. en Principal bij Ernst & Young LLP. Hij behaalde een bachelorgraad aan de Oregon State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
XENCOR, INC. 0,03% | 16-06-2026 | 23.988 ( 0,03% ) | 654 033 $ | 31-08-2026 |
Laatste nieuws over Todd Simpson
Actieve functies van Todd Simpson
| Bedrijven | Functie | Begin |
|---|---|---|
| XENCOR, INC. | Directeur/Bestuurslid | 13-03-2025 |
Shape Therapeutics, Inc.
 Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Directeur/Bestuurslid | 25-06-2024 |
Inovia Capital (US), Inc.
 Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Consultant / Adviseur | 01-01-2017 |
Eerdere bekende functies van Todd Simpson
| Bedrijven | Functie | Einde |
|---|---|---|
| SEAGEN INC. | Financieel Directeur/CFO | 14-12-2022 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Financieel Directeur/CFO | 01-10-2005 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Financieel Directeur/CFO | 01-10-2001 |
| VERICEL CORPORATION | Financieel Directeur/CFO | 01-10-2001 |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Treasurer | 01-12-1995 |
Opleiding van Todd Simpson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
82
Eerstegraads connecties
15
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 15 |
|---|---|
Telios Pharmaceuticals, Inc.
 Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, research | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Oregon State University
 Oregon State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Inovia Capital (US), Inc.
Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Health Technology |
Neoleukin Therapeutics, Inc. /old/
 Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops medicines that transform lives | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
